Clinical Trial Update: ATG Could Improve the Outcome Of Hematopoietic Stem Cell Transplant in Patients With Highly Aggressive T Cell Tumors

View source ↗

Summary

A clinical trial update evaluates anti-thymocyte globulin (ATG) in hematopoietic stem cell transplantation. The trial targets highly aggressive T-cell malignanc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Lymphoblastic Lymphoma

Drugs mentioned

• Anti-thymocyte globulin (ATG) (anti-thymocyte globulin)

Snippet

Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | Conditions: Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma | Status: UNKNOWN